Related Funds
Funds with similar focus
Fund Name | Location |
Akoya Capital Partners | Chicago, Illinois, United States |
Barrick Gold Corporation | Canada, Ontario, Toronto |
Bedrock Ventures | Delhi, Delhi, India |
CerraCap Ventures | California, Costa Mesa, United States |
Craigie Capital | England, London, United Kingdom |
CrossCoin Ventures | California, San Francisco, United States |
Fairfax County Retired Educators | Springfield, United States, Virginia |
Freedom 3 Capital | - |
Gateway | California, Oakland, United States |
Gigafund | Austin, Texas, United States |
Manos Accelerator | California, San Jose, United States |
Naray Mobile Telecom | Seoul, Seoul-t'ukpyolsi, South Korea |
Rabobank Delft Innovation Fund | - |
SMZDM.com | Beijing, Beijing, China |
the SRIW Life Sciences | - |
The University of Oklahoma Foundation | Norman, Oklahoma, United States |
UTA Ventures | Beverly Hills, California, United States |
Viola Partners | Herzliya, Israel, Tel Aviv |
Virginia Catalyst | Richmond, United States, Virginia |
Yiheng Capital | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
OncoLens | 24 Oct 2024 | Atlanta, Georgia, United States | |||
Shimmer | $2M | 10 Jan 2024 | San Francisco, California, United States | ||
Candid | $1M | 21 Sep 2023 | - | ||
Angel Eye Health | $11M | 10 Nov 2022 | Nashville, Tennessee, United States | ||
Biotia | $8M | 23 Aug 2022 | New York, New York, United States | ||
STRIVE | $6M | 29 Jun 2022 | Bothell, Washington, United States | ||
Mployer Advisor | 09 Jun 2022 | Nashville, Tennessee, United States | |||
Curie | 12 Apr 2022 | Menlo Park, California, United States | |||
Heading Health | 18 Feb 2022 | Austin, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
OncoLens | 24 Oct 2024 | Atlanta, Georgia, United States | |||
Shimmer | $2M | 10 Jan 2024 | San Francisco, California, United States | ||
Candid | $1M | 21 Sep 2023 | - | ||
Angel Eye Health | $11M | 10 Nov 2022 | Nashville, Tennessee, United States | ||
Biotia | $8M | 23 Aug 2022 | New York, New York, United States | ||
STRIVE | $6M | 29 Jun 2022 | Bothell, Washington, United States | ||
Mployer Advisor | 09 Jun 2022 | Nashville, Tennessee, United States | |||
Curie | 12 Apr 2022 | Menlo Park, California, United States | |||
Heading Health | 18 Feb 2022 | Austin, Texas, United States |